ABSTRACT Aim: To collate and assess international clinical practice guidelines (CPG) to determine current recommendations guiding oxygen management for respiratory stabilisation of preterm infants at delivery.
resuscitating hypoxic infants. Using air did not increase the risk of death or neurodevelopmental impairment (3) but using pure oxygen was subsequently shown by Vento et al. (4) to be associated with oxidative stress and organ injury.
A meta-analyses of >1300 term infants enrolled in clinical trials comparing air to pure oxygen for resuscitating hypoxic infants subsequently found that using air decreased risk of death by 30% (5) . In 2005, expert committees suggested that air could be used for the delivery room stabilisation of fullterm infants if oxygen was unavailable (6) . In 2006, the Australian Resuscitation Council recommended that air should be used to initiate respiratory support for all newborn infants regardless of gestation (7) . Between 2006 and 2010, pulse oximetry (SpO 2 ) data from healthy, spontaneously breathing term and preterm infants were acquired and showed that SpO 2 did not reach >90% until the 7th to 8th minutes of life unless the infant was given pure oxygen (8) (9) (10) (11) which then led in turn, to oxidative stress and organ injury (4, 12) .
It is now standard practice to initiate term infant resuscitation with air (13) . However, there remains considerable uncertainty about initial FiO 2 for the respiratory stabilisation of preterm infants. A recent survey of 630 clinicians from 25 countries showed that >80% of respondents would initiate preterm infant resuscitation with FiO 2 <0. 4 and that most would not use FiO 2 >0.6 because of concerns of oxidative injury. Most clinicians would then also adjust FiO 2 to meet lower (<50th percentile) SpO 2 targets that were derived from spontaneously breathing, healthy term or preterm infants (10, 14) .
Recently, the To2rpido study, currently the largest study to compare outcomes of preterm infants resuscitated with either high (FiO 2 1.0) or low (FiO 2 0.21) initial levels of oxygen, found in a post hoc analysis an increased risk of death in babies <28 weeks of gestation who were resuscitated with FiO 2 0.21 rather than FiO 2 1.0 [relative risk (RR): 3.9 [95% confidence interval: 1.1 to 13.4]), p = 0.01, (15) . This study had to be curtailed early because of concerns regarding the FiO 2 1.0 arm. However, the uncertainties underlying our practice was shown by the results of a meta-analysis of 504 patients enrolled in eight randomised controlled trials (RCT) of higher (≥FiO 2 0. (16) . A recent follow-up of 253 infants enrolled in an RCT of initial 0.3 or 0.6-0.65 FiO 2 also showed no difference in mortality or neurodevelopment (17) .
Until definitive evidence is available from well-designed and sufficiently large RCT's, clinicians must rely on clinical practice guidelines (CPG) to inform on best practice (18) . The Institute of Medicine defines CPGs as 'statements that include recommendations intended to optimise patient care that are informed by a systematic review of evidence and an assessment of the benefits and harms of alternative care options' (19) . CPGs aim to provide practicing clinicians with the most up to date information in a single document and have been shown to decrease healthcare utilisation and costs and improve practice consistency and patient outcomes (20) .
Taking these considerations into context in a field with rapidly changing evidence, we sought to determine the current status of CPG recommendations for the use of oxygen in the delivery room stabilisation of preterm infants.
METHODS

Search strategy
Systematic searches of three electronic databases (PubMed, Embase and CINAHL) were conducted using the search terms 'clinical practice guidelines', 'preterm', 'oxygen' and 'resuscitation'. No limits were set for the year of publication or language. A grey literature search was also conducted through the Translating Research Into Practice (TRIP) (21) , Guidelines International Network (22) , National Guideline Clearinghouse (23) and National Institute for Health and Care Excellence (NICE) databases (24) . A general internet search (Google) was also conducted in English. International societies, identified through professional contacts, were asked to provide to country-specific guidelines that were not published on the Web.
Study selection
Guidelines were independently reviewed by two investigators (A.W, J.O.). All guidelines, both published and unpublished, multinational, national and local (e.g. area, hospital based, etc.) were included. Guidelines that were not written in English were also included and translated by native speakers for analysis. The original and most recent guidelines were obtained for all cases. Disagreements regarding inclusion of specific guidelines were resolved by consensus between the investigators.
Data extraction and analysis
Data were extracted by one author for information pertaining to: 1. Country of origin 2. Gestation 3. Initial FiO 2 4. Target SpO 2 for the first 10 minutes of life (if any). Other relevant comments were noted. Descriptive statistics are used to present findings. Figure 1 shows the pathway for guideline selection. A total of 45 guidelines were identified (Table 1) International Liaison Committee on Resuscitation is the main international committee, composed of members from the ERC, AHA, Heart and Stroke Foundation of Canada, the Inter American Heart Foundation and the resuscitation councils of Southern Africa and Asia (26) . The NRP is a training programme which disseminates this information internationally, and it is subscribed to by 130 countries and taught in 24 languages (26) . In lower resourced countries, the 'Helping Babies Breathe' programme, an initiative of the AAP in collaboration with the WHO, US Agency for International Development, Saving Newborn Lives and the National Institute of Child Health and Human Development, is used. This programme focuses on airway management and not on FiO 2 manipulation and hence will not be discussed in this study (29) .
RESULTS
Although the 31 national guidelines were informed by ILCOR, some countries stipulated the need to develop local guidelines that could be dynamically adjusted to local resources. Malaysia, for example, acknowledged that even though national guidelines recommended the use of blended oxygen at delivery, these were not disseminated outside of tertiary perinatal centres because most nontertiary Malaysian hospitals still did not have access to equipment to blend oxygen or monitor SpO 2 .
Gestation
The guidelines varied considerably in their recommendations for the use of FiO 2 for different gestations. Nine differentiated between 'term' and 'preterm' infants only as a broad category (ERC (27) preterm infants because of the risk of oxidative stress. All guidelines suggested that pure oxygen (FiO 2 1.0) should be administered if the infant required cardiac compressions. See Table 1 for details.
SpO 2 targets
Recommendations for five-minute SpO 2 targets ranged from 70% (Finland) to 90% (Australia, Indonesia and New Zealand). A number of countries provided their own specific SpO2 targets (Tables 1 and 2 ). Others either adhered to SpO 2 targets suggested by the AHA (13). Five countries did not make any SpO2 recommendations. Three followed SpO 2 targets suggested by the ERC (27) . Malaysia and Latvia were the only countries to provide separate SpO2 targets for preterm and term infants. The AHA (13) and the ILCOR (25) suggested targeting SpO 2 to 'the interquartile range measured in healthy term infants after vaginal birth at sea level' and to the 25th percentile of healthy term babies immediately after birth, respectively.
The evidence
The majority of country-specific guidelines referenced their suggestions to international guidelines despite major expert committees such as ILCOR (25) and AHA/AAP (13) acknowledging the lack of good evidence behind their recommendations. Indeed, these two international committees emphasised that their recommendations were based on low, or at best, moderate, quality of evidence and were given in the face of significant knowledge gaps, especially in regard to the most appropriate time-specific SpO 2 targets for preterm newborns and for long-term outcomes (13, (25) (26) (27) (28) .
DISCUSSION
Our study shows that CPGs for using oxygen to resuscitate preterm infants vary considerably around the world. For example, most CPGs would recommend using FiO 2 < 0.3 for preterm resuscitation, and this is mirrored by clinical opinion, where >80% would initiate resuscitation of Table 2 .
preterm infants with FiO 2 < 0.4 (14) . However, international expert committees acknowledge the lack of good quality evidence behind their recommendations (13, (25) (26) (27) (28) , particularly in regard to longer term outcomes. Preterm infants are physiologically very different to term infants. They are more vulnerable to both hyperoxia due to anti-oxidant deficiency (33) and hypoxia because of pulmonary immaturity. Small studies (11, 12) initially demonstrated that it was possible to initiate preterm resuscitation with lower FiO 2 (e.g. 0.21-0.3) without apparent short-term harm. After this, a paradigm shift in practice has rapidly ensued. For example, our survey found that only 42% of tertiary hospitals in 2008 (34) and 20% of nontertiary units in 2011 (35) in Australia and New Zealand had access to oxygen blending equipment. In 2015, >80% of neonatal clinicians would use FiO 2 0.21-0.4 to initiate preterm infant resuscitation, most (78%) would adjust FiO 2 to target SpO 2 that were at or below the 50th percentile for healthy preterm infants (9) and only four would resuscitate with FiO 2 1.0 because they had no access to oxygen blending equipment (14) .
However, recent information suggests that current practice needs further evaluation. Rabi et al. compared outcomes from 2326 infants <27 weeks of gestation from Canadian NICUs before (n = 1082) and after (n = 1244) Canada changed its recommendations from FiO 2 1.0 to the use of air or lower oxygen, titrated to SpO 2 targets. Adjusted odds ratio (AOR) for severe neurologic injury or death was higher after changes were implemented (AOR: 1.36; 95% CI: 1.11 to 1.66, 36). Lamberska et al. found that using lower oxygen strategies (e.g. commencing with FiO 2 0.3, as recommended by international bodies) to initiate resuscitation of infants 25 weeks of gestation and below, led to poorer recovery from bradycardia and a higher risk of mortality and IVH in comparison with resuscitation with higher oxygen strategies (37) . In the To2rpido study, the largest RCT conducted so far, resuscitation of infants <28 weeks of gestation with FiO 2 0.21 increased risk of death compared to FiO 2 1.0 (15) . Furthermore, whether clinicians are able to achieve the target SpO 2 goals suggested by CPGs is unknown. In an individual patient analysis of 706 preterm infants below 32 weeks of gestation recruited from 8 RCTs of lower (<0.3) v higher (>0.6) initial FiO 2, only 159 (23%) of infants met trial SpO 2 targets (38) . The implication of this is uncertain as each of these studies had slightly different target SpO 2 . However, infants who did not achieve a minimum fiveminute SpO 2 of 85% (the most common target SpO 2 suggested by international committees), whether because of individual trial recommendations or otherwise, were noted to have a significantly increased risk of death [Odds ratio (OR) 1.5, 95% CI: 1.1 to 2.6, p < 0.05] or severe IVH (OR: 2.4, 95% CI: 1.4 to 4.2, 40).
Clinical practice guidelines recommendations have resource implications. For example, a Paraguayan clinician noted that only one hospital in the whole country had access to oxygen blenders. Babies in other hospitals were resuscitated with either air or pure oxygen. Similar responses were obtained from Malaysia, India and Indonesia who all had national guidelines recommending oxygen blending but acknowledged local limitations to equipment and education. In addition, it must be noted that low-resourced countries rely on WHO guidance, which currently lists oxygen as being an anaesthetic gas in its essential medicine list. Finally, whether clinicians adhere to CPGs during routine clinical practice is uncertain. In a systematic review of 30 studies, Farquhar et al. found that clinicians considered CPGs to be good educational tools but were sometimes too rigid to account for patient variability. CPGs were thought to reduce physician autonomy, to oversimplify medicine and to increase the potential of litigation risks (39) . Clinicians also believed that there were considerable external barriers to adopting the recommendations of CPG to their own practice, including language resource limitations and that they may be unable to overcome their own or their peers' practice inertia to initiate changes (40) . This is especially pertinent if CPGs were developed internationally without consideration for local limitations, such as expertise and resources (41) . Maintaining an international consensus on CPGs and the evidence supporting them are clearly important to ensure a high quality globalised approach to resuscitation. However, it must also be acknowledged that local guidelines at the national or regional levels have the capacity to be more dynamic and responsive to change and to the needs of the local clinicians.
In conclusion, we found that CPG recommendations for FiO 2 administration in delivery room resuscitation of preterm infants vary considerably at all levels and that robust evidence for these recommendations are scarce, especially in regard to long-term consequences. There is also no current evidence to show that clinicians are able or willing to follow these guidelines. In order to determine the safest approach, further research from sufficiently large and well-designed clinical trials must be conducted and CPGS must take into consideration the results emanating from these studies at the earliest opportunity to decrease the risk of harm to vulnerable preterm infants.
